BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8451041)

  • 41. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy in recurrent and advanced cervical cancer.
    Kumar L; Bhargava VL
    Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
    Hussain M; Salwen W; Kucuk O; Ensley J
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
    Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer.
    Basaran M; Bavbek SE; Güllü I; Demirelli F; Sakar B; Tenekeci N; Altun M; Yalçin S; Onat H
    J Chemother; 2002 Apr; 14(2):207-13. PubMed ID: 12017379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J; Kellner R; Seeber S
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
    Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
    Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):36-40. PubMed ID: 10697043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study.
    Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Diergarten K; Rastetter J; Hanauske AR
    Oncology; 1997; 54(2):89-95. PubMed ID: 9075777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.
    Powell BL; Craig JB; Muss HB; Zekan PJ; Cooper MR; Schnell FM; Hampton JW; White DR; Smith LR; Capizzi RL
    Am J Clin Oncol; 1988 Oct; 11(5):550-2. PubMed ID: 3177257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Bourhis J; Rivera F; Mesia R; Awada A; Geoffrois L; Borel C; Humblet Y; Lopez-Pousa A; Hitt R; Vega Villegas ME; Duck L; Rosine D; Amellal N; Schueler A; Harstrick A
    J Clin Oncol; 2006 Jun; 24(18):2866-72. PubMed ID: 16717293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neck.
    Wheeler RH; Natale RB; Roshon SG; Baker SR
    J Clin Oncol; 1984 Jul; 2(7):831-5. PubMed ID: 6539813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
    Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
    J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Sandler S; Bonomi P; Taylor B; Showel J; Slayton R; Lerner H
    Cancer Treat Rep; 1984 Sep; 68(9):1163-5. PubMed ID: 6541095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
    Araujo CE; Cervellino JC; Pirisi C; Pannunzio O; Callegari J
    J Surg Oncol; 1991 Mar; 46(3):198-202. PubMed ID: 1901372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.